Clinical Trials in Nashville

Showing 18861-18880 of 20,298 trials

Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid Tumors

NCT00692640

The purpose of this study is to evaluate the safety and tolerability of XL147 in combination with erlotinib (Tarceva®) in subjects with solid tumors. XL147 is a new chemical entity that inhibits PI3 Kinase. Inactivation of PI3K has been shown to inhibit growth and induce apoptosis (programmed cell death) in tumor cells. Erlotinib is an orally administered inhibitor of EGFR (also known as HER1) tyrosine kinase. It was approved by the FDA as a single agent for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC) after failure of at least one prior chemotherapy regimen and in combination with gemcitabine for first line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.

CancerNon-small Cell Lung Cancer

Sanofi35 participantsStarted May 2008

Nashville, Tennessee, United States

UNKNOWNPhase 3< 1 mile

Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer

NCT00706862

The purpose of the study is to determine whether the combination of talactoferrin, carboplatin and paclitaxel improves progression free survival and overall survival in patients with non-small cell lung cancer compared to the combination of paclitaxel and carboplatin alone

Non Small Cell Lung Cancer

Agennix1,100 participantsStarted Feb 2009

Duarte, California, United States • Chicago, Illinois, United States • The Bronx, New York, United States +3 more locations

TERMINATEDNA7.5 miles

Effect of Platelet Concentrate in Treatment of Diabetic Ulcers

NCT00215735

Autologous platelet concentrate will enhance the rate of healing of chronic diabetic wounds

Diabetes

Harvest TechnologiesStarted Jun 2004

Fayetteville, Alaska, United States • Orlando, Florida, United States • St. Petersburg, Florida, United States +6 more locations

Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid Tumors

Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer

Effect of Platelet Concentrate in Treatment of Diabetic Ulcers

Find Trials by Condition in Nashville

Pressure Ulcer Prevention: Turning for Ulcer Reduction

Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis

Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants

A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202)

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection

Safety and Efficacy Study of Isolagen TherapyTM in the Treatment of Nasolabial Fold Wrinkles

Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients

A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's Lymphoma

Use of Cold and Compression Therapy With Total Knee Replacement Patients

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder

Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy

ETEC Logistics Trial (TREK)

Study of Decision Making in Patients Participating in Phase I Clinical Trials

Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer

Travelers' Diarrhea (TD) Vaccine Pivotal Efficacy Study